INDOUS.NS Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: March 16, 2026
Report Source: 2026 3rd Quarter Report
Indo Us Bio-Tech Ltd. Stock Analysis INDOUS.NS
Indo US Bio-Tech Ltd. engages in the research, development, production, marketing and sale of all types of agriculture seeds. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-05-11. The firm operates through the Seed Cultivation, processing and trading segment. The company is involved in crop research and development through breeding, production of seeds, processing, packing and marketing of hybrid and open-pollinated varieties of agricultural crops. Its product portfolio includes a diversified variety of agriculture seeds namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, cumin, coriander, and others. The company has a distribution network in the states of Gujarat, Maharashtra, Madhya Pradesh, Chhattisgarh, Rajasthan, Punjab and others. The company also exports to many countries, namely the United States, New Jersey, Palestine, Cameroon, Kuwait and others.
Read More Indo Us Bio-Tech Ltd (INDOUS.NS) Chart
Key Statistics of Indo Us Bio-Tech Ltd (INDOUS.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹103.20Volume
6315.00P/E Ratio (TTM)
12.9552 Week Range
Market Cap
2.09BAvg. Volume
17.87KDividend Yield
0.24%Financial Metrics & Statements of Indo Us Bio-Tech Ltd (INDOUS.NS)
FAQ's for Indo Us Bio-Tech Ltd (INDOUS.NS)
- According to Musaffa’s Shariah screening methodology, Indo Us Bio-Tech Ltd (INDOUS.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.